Unichem gets USFDA nod for Divalproex; stocks up

MUMBAI: Unichem Laboratories has received approval from USFDA for Divalproex Sodium delayed release tablets USP 125mg, 250mg and 500mg (valproic acid activity). The company already has 9 other ANDA's duly approved and there are some more ANDA's in pipeline.

The stock was at Rs 204.50, up 4.84 per cent on the BSE. It touched a high of Rs 224 and low of Rs 197 in trade so far.